Hologic, Inc’s filing revealed that its Director Madaus Martin D acquired Company’s shares for reported $0.3 million on May 07 ’25. In the deal valued at $55.24 per share,5,445 shares were bought. As a result of this transaction, Madaus Martin D now holds 5,445 shares worth roughly $0.31 million.
Then, Mitchell Essex D sold 24,856 shares, generating $1,897,482 in total proceeds. Upon selling the shares at $76.34, the Chief Operating Officer now owns 27,957 shares.
Before that, Mitchell Essex D bought 24,856 shares. Hologic, Inc shares valued at $1,897,484 were divested by the Officer at a price of $76.34 per share.
Argus downgraded its Hologic, Inc [HOLX] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who decreased its forecast for the stock in early February from “an Outperform” to “a Market perform”. Needham also remained covering HOLX and has decreased its forecast on February 03, 2025 with a “Hold” recommendation from previously “Buy” rating. Wolfe Research started covering the stock on December 13, 2024. It rated HOLX as “a Peer perform”.
Price Performance Review of HOLX
On Friday, Hologic, Inc [NASDAQ:HOLX] saw its stock jump 1.01% to $56.75. Over the last five days, the stock has gained 4.78%. Hologic, Inc shares have fallen nearly -21.28% since the year began. Nevertheless, the stocks have fallen -25.43% over the past one year. While a 52-week high of $84.67 was reached on 01/06/25, a 52-week low of $51.90 was recorded on 05/06/25. SMA at 50 days reached $59.71, while 200 days put it at $72.46.
Levels Of Support And Resistance For HOLX Stock
The 24-hour chart illustrates a support level at 56.20, which if violated will result in even more drops to 55.66. On the upside, there is a resistance level at 57.06. A further resistance level may holdings at 57.37. The Relative Strength Index (RSI) on the 14-day chart is 46.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.52, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.18%. Stochastics %K at 55.53% indicates the stock is a holding.
The most recent change occurred on December 10, 2024 when Needham resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $90.
